bluebird bio Inc.

NASDAQ: BLUE · Real-Time Price · USD
4.97
0.00 (0.00%)
At close: May 30, 2025, 3:59 PM

bluebird bio Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-240.72M -211.91M -266.58M -819.38M
Depreciation & Amortization
61.24M 28.52M 5M 19.65M
Stock-Based Compensation
13.74M 19.43M 35.19M 127.92M
Other Working Capital
-157.43M -67.92M -30.98M -5.6M
Other Non-Cash Items
35.76M -21.37M -87.44M 17.62M
Deferred Income Tax
n/a n/a n/a 568K
Change in Working Capital
-130.04M -49.72M -39.12M 17.98M
Operating Cash Flow
-260.02M -235.05M -352.95M -635.64M
Capital Expenditures
-2.6M -9.06M -13.21M -23M
Cash Acquisitions
n/a n/a n/a 8.5M
Purchase of Investments
n/a -43.3M n/a -451.39M
Sales Maturities Of Investments
n/a 114.37M 161.66M 926.65M
Other Investing Acitivies
6.5M 88.06M 102M 101.8M
Investing Cash Flow
3.9M 154.95M 250.45M 562.56M
Debt Repayment
-14.63M -54.37M -36.73M n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
102.1M 2.42M 16K -168.93M
Financial Cash Flow
87.47M 196.25M 54.25M -93.95M
Net Cash Flow
-168.65M 116.15M -48.25M -167.04M
Free Cash Flow
-262.62M -244.1M -366.16M -658.64M